Reading Time: 3 minutes
Introduction
Parkinson’s disease (PD) is a chronic, progressive neurodegenerative disorder marked by motor impairments like tremor, rigidity, and bradykinesia. Non-motor symptoms such as depression, anxiety, and cognitive decline further compound its …
Read MoreReading Time: 2 minutes
Glucagon-like peptide-1 receptor (GLP-1R) agonists are gaining attention in Parkinson’s disease (PD) treatment due to their potential to modify disease progression. This literature review synthesizes recent findings, highlights gaps, particularly …
Reading Time: 2 minutes
Introduction
Understanding how the brain changes with age is crucial for developing interventions to maintain cognitive health in older adults. This literature review examines recent research on age-related brain changes, highlighting …
Read MoreReading Time: 2 minutes
Introduction Parkinson’s disease (PD) and melanoma, two seemingly unrelated conditions, have been intriguing researchers with their potential link. This literature review delves into recent studies that explore this connection, providing …